These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37630190)

  • 61. Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype.
    Pluta R; Ułamek-Kozioł M; Czuczwar SJ
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545070
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Angiotensin converting enzyme and Alzheimer's disease].
    Kugaevskaia EV
    Biomed Khim; 2013; 59(1):5-24. PubMed ID: 23650720
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Alzheimer disease--contribution of renin-angiotensin system to Alzheimer disease progression].
    Ohrui T
    Nihon Rinsho; 2012 Sep; 70(9):1599-603. PubMed ID: 23012810
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of renin-angiotensin-aldosterone system inhibitors on plasma levels of angiotensin-converting enzyme 2.
    Zimmermann T; Walter JE; Lopez-Ayala P; Strebel I; Amrein M; Koechlin M; Honegger U; Mueller C;
    ESC Heart Fail; 2021 Apr; 8(2):1717-1721. PubMed ID: 34596976
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change in patients with dementia due to Alzheimer's disease.
    de Oliveira FF; Bertolucci PH; Chen ES; Smith MC
    J Alzheimers Dis; 2014; 42 Suppl 3():S321-4. PubMed ID: 24577465
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of three angiotensin-converting enzyme inhibitors on kynurenic acid production in rat kidney in vitro.
    Zakrocka I; Kocki T; Turski WA
    Pharmacol Rep; 2017 Jun; 69(3):536-541. PubMed ID: 28364692
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation?
    Zou K; Michikawa M
    Rev Neurosci; 2008; 19(4-5):203-12. PubMed ID: 19145983
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
    Wang GM; Li LJ; Tang WL; Wright JM
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012569. PubMed ID: 33089502
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.
    Giatras I; Lau J; Levey AS
    Ann Intern Med; 1997 Sep; 127(5):337-45. PubMed ID: 9273824
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition.
    Chappell MC; Gomez MN; Pirro NT; Ferrario CM
    Hypertension; 2000 Jan; 35(1 Pt 2):348-52. PubMed ID: 10642323
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study.
    Edwards JD; Ramirez J; Callahan BL; Tobe SW; Oh P; Berezuk C; Lanctôt K; Swardfager W; Nestor S; Kiss A; Strother S; Black SE;
    J Alzheimers Dis; 2017; 59(3):1113-1122. PubMed ID: 28731439
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neuroprotective Effect of Lentivirus-Mediated FGF21 Gene Delivery in Experimental Alzheimer's Disease is Augmented when Concerted with Rapamycin.
    Kakoty V; C SK; Yang CH; Kumari S; Dubey SK; Taliyan R
    Mol Neurobiol; 2022 May; 59(5):2659-2677. PubMed ID: 35142986
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Angiotensin-converting enzyme inhibitors in the treatment of arterial hypertension].
    Babadzhan VD
    Lik Sprava; 2000 Mar; (2):19-26. PubMed ID: 10862468
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevention of dementia: lessons from SYST-EUR and PROGRESS.
    Hanon O; Forette F
    J Neurol Sci; 2004 Nov; 226(1-2):71-4. PubMed ID: 15537524
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B; Nussberger J; Juillerat L; Brunner HR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of ACE Retards Tau Hyperphosphorylation and Signs of Neuronal Degeneration in Aged Rats Subjected to Chronic Mild Stress.
    AbdAlla S; El Hakim A; Abdelbaset A; Elfaramawy Y; Quitterer U
    Biomed Res Int; 2015; 2015():917156. PubMed ID: 26697495
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension.
    Stergiou GS; Skeva II; Baibas NM; Roussias LG; Kalkana CB; Achimastos AD; Mountokalakis TD
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):937-41. PubMed ID: 10836730
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Riluzole and its prodrugs for the treatment of Alzheimer's disease.
    Al-Horani RA
    Pharm Pat Anal; 2023 Mar; 12(2):79-85. PubMed ID: 37140357
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
    Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
    J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.